News
20/06/2024
Immunology of Diabetes Congress, IDS 2024.
We are pleased to invite you to the 20th edition of the Immunology of Diabetes Congress, IDS 2024. This year, the IDS conference will take place in the old city of Bruges, Belgium, between November 4-8, 2024.
This conference unites basic and translational scientists, clinicians, pharmaceutical companies and foundations interested in Type 1 Diabetes. Together we strive to better predict, prevent and eventually cure T1D. Check out our latest program to discover the wide range of topics.
Registration and abstract submission are NOW open! We encourage young investigators to apply for oral and poster presentations, as this is an exciting opportunity to engage in new collaborations and discuss novel insights with experts in the field.
Looking forward to welcoming you all at IDS Bruges!
On behalf of the organizing committee,
Chantal Mathieu, Lut Overbergh, Decio Eizirik, Conny Gysemans, Roberto Mallone, Sylvaine You
27/02/2024
BES meeting 2024
The 2024 BES meeting is sheduled on Friday October 11th and Saturday October 12th – in Dolce La Hulpe.
The prevous edtion of the BES meeting allowed us to gather more than 130 participants.
We invite you to experience the atmosphere through this teaser video.
The abstracts of the submissions for the Young Investigator award can be consulted online in Endocrine Abstracts; the 2023 abstract book is also available for download here.
We are in the process of developing this year’s scientific program. The preliminary program is now online.
The focus of this year’s program will be on
- Aging males
- Diabetes technology
- Neuro-endocrine tumors
- Ovarian failure
- Thyroid disease
We now call upon the young investigators and endocrinologists in training to submit their abstracts for the Young Investigator Award.
Deadline is July 21th. The instructions for submission can be consulted here.
25/11/2022
Appeal to collaborate in a survey
You are kindly invited to participate in a survey exploring testosterone methodology in clinical units and laboratories throughout Europe.
This survey is part of a larger project funded by research foundation Flanders (FWO): ‘Better estimates of hormonal exposure to improve diagnosis and treatment in endocrine diseases (BEED-ED), which aims to improve accuracy, accessibility and clinical applicability of (free) steroid hormone levels.
Currently, different methods are used to measure testosterone and SHBG, hampering harmonized clinical use of (free) testosterone. With this survey, we want to map current clinical practices on methods to measure testosterone and SHBG in clinical units and laboratories in Europe. The results of this survey will be used to propose harmonization efforts for testosterone and SHBG measurements.
The survey is accessible here. For those interested: have a look at the protocol summary
Prof. Dr. Leen Antonio, MD, PhD – Endocrinology UZ Leuven, Belgium
Prof. Dr. Bruno Lapauw, MD, PhD – Endocrinology UZ Gent, Belgium
Dr. Tom Fiers, MD, PhD – Laboratory Medicine UZ Gent, Belgium
Nick Narinx, MD – Clinical Chemistry UZ Leuven, Belgium
